Back to companies

Entrada Therapeutics, Inc.

TRDAUSNASDAQPharmaceuticals & Healthcare

Entrada Therapeutics, Inc.

Revenue
$25.4mn
YoY -87.9%
Operating income
-$157.9mn
FY2025
Employees
—
Founded
—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API